Linscomb Wealth’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,089
Closed -$207K 287
2018
Q3
$207K Sell
1,089
-235
-18% -$43.2K 0.02% 269
2018
Q2
$221K Buy
+1,324
New +$213K 0.02% 252
2018
Q1
Sell
-1,470
Closed -$240K 280
2017
Q4
$240K Buy
1,470
+80
+6% +$14.4K 0.02% 246
2017
Q3
$285K Buy
1,390
+90
+7% +$20.9K 0.02% 219
2017
Q2
$316K Sell
1,300
-30
-2% -$7.05K 0.03% 203
2017
Q1
$318K Sell
1,330
-12
-0.9% -$2.79K 0.03% 196
2016
Q4
$282K Sell
1,342
-103
-7% -$21.3K 0.03% 213
2016
Q3
$333K Sell
1,445
-366
-20% -$89.4K 0.03% 195
2016
Q2
$419K Buy
1,811
+30
+2% +$6.92K 0.04% 175
2016
Q1
$477K Buy
1,781
+23
+1% +$6.58K 0.05% 164
2015
Q4
$549K Buy
1,758
+191
+12% +$56.9K 0.06% 143
2015
Q3
$426K Sell
1,567
-94
-6% -$28.9K 0.05% 179
2015
Q2
$504K Sell
1,661
-41
-2% -$12.2K 0.06% 168
2015
Q1
$507K Buy
1,702
+542
+47% +$155K 0.05% 172
2014
Q4
$299K Buy
1,160
+59
+5% +$14.7K 0.03% 223
2014
Q3
$266K Buy
+1,101
New +$246K 0.03% 231

Other funds holding AGN

Linscomb Wealth's AGN Position: Q4 2018 in Review

Linscomb Wealth sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,089 shares — an estimated $207K sold.

Linscomb Wealth first reported a position in AGN in Q3 2014 and held it in 16 quarters. The position peaked at $549K in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Linscomb Wealth reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Linscomb Wealth sold 1,089 Allergan plc shares in Q4 2018, an estimated $207K.
  • Linscomb Wealth first reported a position in Allergan plc in Q3 2014 and held it in 16 quarters.
  • Linscomb Wealth's Allergan plc position peaked at $549K in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Linscomb Wealth's 13F filing for Q4 2018, filed 8 Feb 2019.